Related Experiment Video
Updated: Nov 12, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Malonyl coenzyme A decarboxylase deficiency with a novel mutation
Cigdem S Kasapkara1, Burcu Civelek Ürey2, Ahmet C Ceylan3
1Department of Pediatric Metabolism, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey.
Abstract:
Malonyl-CoA, a product of acetyl-CoA carboxylase is a metabolic intermediate in lipogenic tissues that include liver and adipose tissue, where it is involved in the de novo fatty acid synthesis and elongation. Malonyl-CoA decarboxylase (MLYCD, E.C.4.1.1.9), a 55-kDa enzyme catalyses the conversion of malonyl-CoA to acetyl-CoA and carbon dioxide, thus providing a route for disposal of malonyl-CoA from mitochondria and peroxisomes, whereas in the cytosol, the malonyl-CoA pool is regulated by the balance of MLYCD and acetyl-CoA carboxylase activities. So far, 34 cases with different MLYCD gene defects comprising point mutations, stop codons, and frameshift mutations have been reported in the literature. Here, we describe the follow-up of a patient affected by malonic aciduria upon neonatal onset. Molecular analysis showed novel homozygous mutations in the MLYCD gene. Our findings expand the number of reported cases and add a novel variant to the repertoire of MLYCD mutations.
Related Concept Videos
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Inborn Errors of Metabolism
Animal Mitochondrial Genetics
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Amino Acid Catabolism

